Part of the Life Sciences Commons

Works by David O. Matson in Life Sciences

2011

Efficacy of the Pentavalent Rotavirus Vaccine, RotaTeq (RV5), Between Doses of a 3-Dose Series and With Less Than 3 Doses (Incomplete Regimen), Penelope D. Dennehy, Timo Vesikari, David O. Matson, Robbin F. Itzler, Michael J. Dallas, Michelle G. Goveia, Mark J. DiNubile, Penny M. Heaton, Max Ciarlet
Community & Environmental Health Faculty Publications

PDF

2010

Robustness of the Healthcare Utilization Results From the Rotavirus Efficacy and Safety Trial (REST) Evaluating the Human-Bovine (WC3) Reassortant Pentavalent Rotavirus Vaccine (RV5), Robbin Itzler, Gary Koch, David O. Matson, Leif Gothefors, Pierre Van Damme, Mark J. DiNubile, Penny M. Heaton
Community & Environmental Health Faculty Publications

PDF

2007

On a Multinational Assessment of Rotavirus Disease in Europe, David O. Matson
Community & Environmental Health Faculty Publications

PDF